Education
About Us
Working with TipRanks
Follow Us
Andrew P Aromando Insider Profile
4 Followers
Andrew P Aromando, Chief Business Officer at Oncolytics Biotech, holds 25.50K shares in Oncolytics Biotech (Ticker: ONCY). Most recently, Andrew P Aromando Bought $25,500 shares of Oncolytics Biotech on Jul 18, 2025 for an estimated value of 30.24K.
Andrew P Aromando has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Andrew P Aromando's holdings
Insider Roles
Chief Business Officer
Roles that Andrew P Aromando holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Andrew P Aromando
Andrew P Aromando's Trading History
List of latest transactions for each holding click on a transaction to see Andrew P Aromando's performance on stock
You May Also Like
Andrew P Aromando insider profile FAQ
What is the percentage of profitable transactions made by Andrew P Aromando?
The percentage of profitable transactions made by Andrew P Aromando is ―.
What is the average return per transaction made by Andrew P Aromando?
The average return per transaction made by Andrew P Aromando is ―.
What stocks does Andrew P Aromando hold?
Andrew P Aromando holds: ONCY stocks.
What was Andrew P Aromando’s latest transaction?
Andrew P Aromando latest transaction was an Informative Buy of $30.24K.
What was Andrew P Aromando's most profitable transaction?
Andrew P Aromando’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Andrew P Aromando's role in Oncolytics Biotech?
Andrew P Aromando's role in Oncolytics Biotech is Chief Business Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.